Biotech

All Articles

Lilly- backed weight loss biotech data IPO

.After elevating $170 million back in February, metabolic disease-focused BioAge Labs has filed to d...

Aelis' marijuana usage drug fails phase 2b, driving Indivior to rethink $100M alternative

.Aelis Farma's chances of securing a quick, beneficial choice on a $100 million possibility repaymen...

ProKidney standstills phase 3 test certainly not needed to have for cell therapy approval

.ProKidney has actually ceased one of a set of phase 3 tests for its own cell treatment for kidney i...

Vaxcyte surges on 'remarkable' 31-valent PCV succeed against Pfizer

.Vaxcyte unveiled what analysts referred to as "remarkable" phase 1/2 information for its 31-valent ...

Recursion's human brain health condition test shows little proof of efficiency

.Recursion has actually discovered by means of a very early exam of its tech-enabled strategy to med...

Acepodia, Pfizer click on all together for chemistry-based tissue treatment

.Phone it a scenario of excellent chemical make up: Acepodia, a biotech based upon Nobel Champion sc...

Praxis epilepsy medicine decreases confiscations in phase 2 hearing

.Praxis Preciseness Medicines has actually racked up yet another midphase gain in epilepsy this year...

Three directors surrender as Dyne posts blended data for DMD applicant

.After getting away from a scientific hold a number of years back, Dyne Rehab has actually shown bra...

Arrowhead fires off phase 3 records in rare metabolic ailment in front of market encounter Ionis

.Arrowhead Pharmaceuticals has actually shown its own hand in advance of a possible showdown with Io...

Pfizer, Valneva present lyme condition chance helpful for second enhancer

.Pfizer and also Valneva might have regarding 2 more years to wait just before they produce the firs...